These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9100819)

  • 1. Perspectives on alternatives to the eye irritation test: industry, public interest, government.
    Bruner LH; Spira H; Balls M; Hill RN
    Food Chem Toxicol; 1997 Jan; 35(1):165-6. PubMed ID: 9100819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical application of non-whole animal alternatives: summary of IRAG workshop on eye irritation testing. Interagency Regulatory Alternatives Group.
    Bradlaw J; Gupta K; Green S; Hill R; Wilcox N
    Food Chem Toxicol; 1997 Jan; 35(1):175-8. PubMed ID: 9100821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of eye irritation potential: statistical analysis and tier testing strategies.
    de Silva O; Cottin M; Dami N; Roguet R; Catroux P; Toufic A; Sicard C; Dossou KG; Gerner I; Schlede E; Spielmann H; Gupta KC; Hills RN
    Food Chem Toxicol; 1997 Jan; 35(1):159-64. PubMed ID: 9100818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternatives to ocular irritation testing in animals.
    Atkinson KA; Fentem JH; Clothier RH; Balls M
    Lens Eye Toxic Res; 1992; 9(3-4):247-58. PubMed ID: 1301784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro alternatives to Draize eye irritation test].
    Zhou J; Yang M; Yang X; He X
    Wei Sheng Yan Jiu; 2004 Jul; 33(4):515-7. PubMed ID: 15461295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRAG working group 1. Organotypic models for the assessment/prediction of ocular irritation. Interagency Regulatory Alternatives Group.
    Chamberlain M; Gad SC; Gautheron P; Prinsen MK
    Food Chem Toxicol; 1997 Jan; 35(1):23-37. PubMed ID: 9100813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical planning and analysis considerations in the evaluation of in vitro alternatives to whole animal use for eye irritation testing.
    Feder P; Carr G; Holzhütter HG; Lovell D; Springer J
    Food Chem Toxicol; 1997 Jan; 35(1):167-74. PubMed ID: 9100820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Short Time Exposure (STE) test for predicting eye irritation potential: intra-laboratory reproducibility and correspondence to globally harmonized system (GHS) and EU eye irritation classification for 109 chemicals.
    Takahashi Y; Hayashi K; Abo T; Koike M; Sakaguchi H; Nishiyama N
    Toxicol In Vitro; 2011 Oct; 25(7):1425-34. PubMed ID: 21513790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the OptiSafe™ eye irritation test.
    Choksi N; Lebrun S; Nguyen M; Daniel A; DeGeorge G; Willoughby J; Layton A; Lowther D; Merrill J; Matheson J; Barroso J; Yozzo K; Casey W; Allen D
    Cutan Ocul Toxicol; 2020 Sep; 39(3):180-192. PubMed ID: 32586141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EpiOcular™ Eye Irritation Test is the Method of Choice for the In Vitro Eye Irritation Testing of Agrochemical Formulations: Correlation Analysis of EpiOcular Eye Irritation Test and BCOP Test Data According to the UN GHS, US EPA and Brazil ANVISA Classification Schemes.
    Kolle SN; Rey Moreno MC; Mayer W; van Cott A; van Ravenzwaay B; Landsiedel R
    Altern Lab Anim; 2015 Jul; 43(3):181-98. PubMed ID: 26256396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Draize test and alternative methods for evaluating irritation from chemical substances].
    Moskalewski S; Mystkowska ET; Kiss E
    Rocz Panstw Zakl Hig; 1995; 46(2):163-8. PubMed ID: 8533034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the eye irritation test.
    Chu IH; Toft P
    Toxicol Ind Health; 1993; 9(6):1017-25. PubMed ID: 8191500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the eye irritating properties of chemicals by applying alternatives to the Draize rabbit eye test: the use of QSARs and in vitro tests for the classification of eye irritation.
    Gerner I; Liebsch M; Spielmann H
    Altern Lab Anim; 2005 Jun; 33(3):215-37. PubMed ID: 16180977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The status of eye irritancy testing: a regulatory perspective.
    Wilcox NL
    Lens Eye Toxic Res; 1992; 9(3-4):259-71. PubMed ID: 1301785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CON4EI: CONsortium for in vitro Eye Irritation testing strategy - EpiOcular™ time-to-toxicity (EpiOcular ET-50) protocols for hazard identification and labelling of eye irritating chemicals.
    Kandarova H; Letasiova S; Adriaens E; Guest R; Willoughby JA; Drzewiecka A; Gruszka K; Alépée N; Verstraelen S; Van Rompay AR
    Toxicol In Vitro; 2018 Jun; 49():34-52. PubMed ID: 28866024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CON4EI: Development of serious eye damage and eye irritation testing strategies with respect to the requirements of the UN GHS/EU CLP hazard categories.
    Verstraelen S; Van Rompay AR
    Toxicol In Vitro; 2018 Jun; 49():2-5. PubMed ID: 28629855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CON4EI: CONsortium for in vitro Eye Irritation testing strategy.
    Van Rompay AR; Verstraelen S; Blaauboer BJ
    Toxicol In Vitro; 2018 Jun; 49():1. PubMed ID: 29685209
    [No Abstract]   [Full Text] [Related]  

  • 19. Porcine Corneal Ocular Reversibility Assay (PorCORA) predicts ocular damage and recovery for global regulatory agency hazard categories.
    Piehl M; Carathers M; Soda R; Cerven D; DeGeorge G
    Toxicol In Vitro; 2011 Dec; 25(8):1912-8. PubMed ID: 21708243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposed eye irritation testing strategy to reduce and replace in vivo studies using Bottom-Up and Top-Down approaches.
    Scott L; Eskes C; Hoffmann S; Adriaens E; Alepée N; Bufo M; Clothier R; Facchini D; Faller C; Guest R; Harbell J; Hartung T; Kamp H; Varlet BL; Meloni M; McNamee P; Osborne R; Pape W; Pfannenbecker U; Prinsen M; Seaman C; Spielmann H; Stokes W; Trouba K; Berghe CV; Goethem FV; Vassallo M; Vinardell P; Zuang V
    Toxicol In Vitro; 2010 Feb; 24(1):1-9. PubMed ID: 19490935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.